---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-102033"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2024-09-23T23:59:59+00:00"
generated_at: "2026-05-31T02:21:58.977485+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech raises $8M in registered direct offering and private placements

## Summary
- Raised $8M gross from sale of 3,939,394 shares at $1.65 and warrants to institutional investors; CEO also purchased shares/warrants.
- Private placement warrants exercisable at $1.84, six months post-issuance, 5.5-year term.
- CEO Lindsay Rosenwald purchased 763,359 shares at $1.84 and warrants at $0.125 per warrant.
- Proceeds for R&D, clinical trials, working capital; lock-up agreements for insiders for 60 days after effective date.
- A.G.P./Alliance Global Partners acted as placement agent with 7% commission (3.5% for insider).

## SEC filing metadata
- accession: 0001104659-24-102033
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2024-09-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000110465924102033/0001104659-24-102033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000110465924102033/tm2424497d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-102033
- JSON: https://secwatch.observer/filing/0001104659-24-102033.json
- Plain text: https://secwatch.observer/filing/0001104659-24-102033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.